The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria

Table 1 Absolute and relative change in the prescription rate between Quarter 3 (Q3) of 2020 and Quarter 4 (Q4) of 2021

Medication	Age	Sex	2020 3rd Quarter	2021 4th quarter	Change in Percent %
Antidepressants
Antidepressants	10–14	Female	2.05	4.18	103.54
Antidepressants	10–14	Male	1.48	1.99	34.69
Antidepressants	15–19	Female	15.83	23.03	45.47
Antidepressants	15–19	Male	7.81	9.53	22.04
Antidepressants	All ages	Female	79.77	80.96	1.49
Antidepressants	All ages	Male	41.52	42.37	2.04
Antipsychotics
Antipsychotics	10–14	Female	1.22	2.13	74.26
Antipsychotics	10–14	Male	2.73	3.14	14.78
Antipsychotics	15–19	Female	5.12	7.65	49.32
Antipsychotics	15–19	Male	4.68	5.36	14.40
Antipsychotics	All ages	Female	21.01	22.14	5.38
Antipsychotics	All ages	Male	16.04	16.94	5.61

This table displays the change in the respective prescription rates between the third quarter of 2020, the beginning of the effect, and the fourth quarter of 2021, the end of the observation period

ISSN: 1753-2000